Nicholas Grund to Resign as Akebia's Chief Commercial Officer, Will Serve as Consultant

Akebia Therapeutics (AKBA) dosed the first patient in a Phase 2 trial of ebribafusp for rare kidney diseases. The trial will enroll up to 30 patients and evaluate safety, proteinuria, and kidney function. Ebribafusp aims to inhibit complement activation in kidney tissue. Initial data is expected in 2027. AKBA's stock is currently at $0.90, down 4.87%.

Akebia Therapeutics, Inc. (AKBA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights Q2 2026 Vafseo® (vadadustat) net product revenues grew to $21.3 million; more than 10,500 p atients now on therapy Advancement of rare kidney disease pipeline continues with ini

Sysco (SYY) and Teamsters Locals 630 and 848 have agreed to end a strike in Los Angeles. The agreement aims to resolve disruptions for customers, employees, and communities. Sysco is a food distribution company.

CoreWeave's 5-year CDS spreads exceeded 1,140 bps, up 16% from a week ago, indicating increased credit risk. The company's bonds yield 15.78%, and it has $51B in debt. Shares rose 5.94% after an initial decline. Analysts note strong demand but negative cash flow. CEO says backlog covers debt, per Deutsche Bank.

CoreWeave, a neocloud compute provider, faces rising bond yields at 15% and a 60% chance of default, according to ICE Data Services. Its shares dropped 16% in a week. The company has $50B in debt and reported a net loss of $626M, despite revenue growth. Meta and OpenAI have committed to large contracts, but analysts warn of industry-wide financial challenges.

Netflix's chief content officer Bela Bajaria is leaving after a decade, with Peter Rice, former Disney and 21st Century Fox executive, taking over. The change follows recent layoffs and a 40% stock decline. Bajaria oversaw a shift towards broad-based scripted and unscripted content. Rice is praised for his extensive industry experience and leadership. Netflix's share price has dropped due to viewership concerns and competition.